Combined Estrogen Progestogen Contraceptives and Combined Estrogen Progestogen Menopausal Therapy IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 91 1st Edition by International Agency For Research On Cancer ISBN 9283212916 9789283212911

Combined Estrogen Progestogen Contraceptives and Combined Estrogen Progestogen Menopausal Therapy IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 91 1st Edition by International Agency For Research On Cancer – Ebook PDF Instant Download/Delivery: 9283212916, 9789283212911

Full download Combined Estrogen Progestogen Contraceptives and Combined Estrogen Progestogen Menopausal Therapy IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 91 1st Edition after payment

 

Product details:

ISBN 10: 9283212916

ISBN 13: 9789283212911 

Author: International Agency For Research On Cancer 

Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future.

This ninety-first volume of the IARC Monographs contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. The hormonal drugs reviewed in this volume involve co-administration of an estrogen and a progestogen. Studies that did not provide information on the use of combined estrogen-progestogen agents are not reviewed. It should also be noted that this volume reviews only studies that are publicly available and therefore does not include pharmaceutical test results that are not in the public domain.

The evaluations developed in this volume identify specific forms of cancer for which the risk is increased or decreased by combined estrogen-progestogen contraceptives and provide information that will help address the health concerns and well-being of hundred of millions of women worldwide.

Table of contents:

Combined Estrogen–Progestogen Contraceptives

1. Exposure Data

2. Studies of Cancer in Humans

3. Studies of Cancer in Experimental Animals

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms

5. Summary of Data Reported and Evaluation

6. References

Combined Estrogen–Progestogen Menopausal Therapy

1. Exposure Data

2. Studies of Cancer in Humans

3. Studies of Cancer in Experimental Animals

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms

5. Summary of Data Reported and Evaluation

6. References

People also search for:

combined estrogen progestogen oral contraceptives
    
combined estrogen–progestin oral contraceptives (ocs)
    
combined estrogen-progestogen
    
combined estrogen progestogen menopausal therapy
    
combined estrogen/progestin contraceptives
    
combined estrogen and progestogen containing hormonal contraception

Tags: International Agency For Research On Cancer, Combined, Estrogen, Progestogen, Contraceptives, Menopausal, Therapy, IARC, Monographs, Evaluation, Carcinogenic, Risks, Humans, Volume 91